IMPERIAL BEACH TECHNOLOGY CORP.

Scientific Research and Development Division

Clinical Case Summary with Recommendations

Subject:

A 26-year-old female with a history of long-term selective serotonin reuptake inhibitor (SSRI) therapy presents with significant psychiatric instability following medication discontinuation. The patient had been maintained on SSRI treatment continuously since approximately age 16, representing about ten years of sustained pharmacologic management for an underlying psychiatric condition.

Medication History

The patient discontinued the SSRI approximately three months prior to the current evaluation. It is unclear whether discontinuation occurred through a medically supervised taper or abrupt cessation. Given the prolonged duration of use, stopping treatment after a decade of continuous serotonergic modulation represents a substantial neurochemical change that can affect mood regulation, cognition, and behavioral stability.

Clinical Course Since Discontinuation

Within the three-month period following cessation of the medication, the patient has experienced repeated psychiatric hospitalizations, indicating significant deterioration in mental health status. The recurrent admissions suggest persistent instability rather than an isolated episode, raising concerns about relapse of the underlying psychiatric disorder or complications related to medication withdrawal.

Current Presentation

The patient is currently described as confused and disoriented, including an inability to identify where she is. Disorientation to place is a serious cognitive symptom that may reflect impairment in awareness, attention, or memory processing.

Observed concerns include:

• confusion regarding surroundings
• inability to recognize location
• impaired situational awareness
• possible disorientation to time or context
• fluctuating cognitive clarity

These symptoms indicate an acute disturbance in mental status and require urgent clinical attention.

Clinical Significance

In this context, disorientation may indicate several potential conditions, including:

• relapse or worsening of the underlying psychiatric disorder
• antidepressant discontinuation–related destabilization
• severe depressive or manic episode
• psychotic disorder or acute dissociative state

• delirium related to medical causes such as infection, dehydration, metabolic imbalance, or substance exposure
• neurological conditions affecting cognition or awareness

\

Because the patient had prolonged SSRI exposure beginning in adolescence, the sudden removal of pharmacologic support may contribute to significant changes in serotonergic regulation and neuropsychiatric stability.

Clinical Recommendations

1. Immediate Medical Evaluation

Disorientation and confusion should be treated as urgent clinical symptoms. The patient should receive immediate evaluation in an emergency department or acute psychiatric facility to assess both medical and psychiatric causes.

2. Comprehensive Medical Workup

A full medical assessment should be performed to rule out organic causes of altered mental status. Recommended evaluations may include:

• neurological examination
• complete blood panel and metabolic profile
• toxicology screening
• hydration and electrolyte assessment
• infection screening if clinically indicated
• brain imaging if neurological symptoms are present

3. Psychiatric Assessment

A comprehensive psychiatric evaluation is necessary to determine whether the patient is experiencing:

• relapse of the original psychiatric condition
• medication withdrawal-related instability
• psychosis or manic episode
• severe depressive episode with cognitive impairment

4. Medication Review

A psychiatrist should evaluate the patient’s prior treatment regimen and consider:

• reintroduction of the previous SSRI if clinically appropriate
• initiation of an alternative antidepressant or psychiatric medication
• use of mood stabilizers or antipsychotic medication if symptoms warrant
• development of a carefully structured tapering strategy if medication adjustments are required

5. Stabilization and Monitoring

If the patient continues to demonstrate confusion or impaired orientation, inpatient stabilization and monitoring may be necessary to ensure safety and consistent observation during treatment adjustments.

6. Long-Term Care Planning

Following stabilization, the patient may benefit from:

• structured outpatient psychiatric follow-up
• psychotherapy or behavioral health treatment
• medication adherence monitoring
• coordinated care between psychiatric and primary care providers